Market Access Transformation specializes in developing cutting edge technologies that enable the healthcare community to gather and exchange insight that assess the real-world potential of their products.
Global Payer Insight On Demand
VALUE STRATEGY INSIGHT
Target Product Profile Assessment (TPP)
validate clinical assumptions and access opportunities with payers.
Payer Evidence Planning
test the strength of your evidence generation plan to meet payers needs and expectations.
Value Proposition and Messaging Testing
test your value proposition and corresponding messaging at various stages to ensure relevance and high-impact with payers.
Value Communication Planning
vet and prioritize key value messages to help identify how your product is most impactful to different payer types through RPR™.
BY DEVELOPMENT STAGE
Early Stage Development
understand treatment landscape, unmet need, shape TPP, make go/no-go decisions, etc.
support pricing & reimbursement objectives, economic modeling, vet the design of clinical trials parameters, and more by getting payer feedback.
evidence generation planning, update pricing & reimbursement strategy directly with payers.
Late Stage / Launch
validate your product’s clinical and commercial strategies with payers across different markets.
test the impact of new indication and the overall value of your product by obtaining feedback from payers.
validate your economic modeling framework and evidence generation strategy.
understand barriers to access, key decisions and success factors by engaging directly with payers in emerging markets.
Medical Device | Diagnostics | Vaccines
understand product value evaluation and funding pathways strategy for your product by assessing payer insight.
Pricing, Reimbursement and Contracting Strategy
test your early and late price planning, indication-based pricing scenarios, willingness to pay, global pricing strategy, reimbursement objectives and scenario planning, launch and LoE price optimization, contracting strategy and more with RPR™.